Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Simpson-Golabi-Behmel syndrome 1Recurrence 1Hepatoblastoma 1

Interventions

X-Rays 7Specimen Handling 7Phantoms, Imaging 7Magnetic Resonance Spectroscopy 6Nuclear Medicine Department, Hospital 5Biopsy 5Cisplatin 4Vincristine 3Fluorouracil 3Doxorubicin 3Carboplatin 3ulixertinib 2tipifarnib 2tazemetostat 2sodium thiosulfate 2selpercatinib 2palbociclib 2larotrectinib 2ivosidenib 2fludarabine 2erdafitinib 2ensartinib 2Vorinostat 2Temozolomide 2Sorafenib 2Oxaliplatin 2LY3023414 2Irinotecan 2Gemcitabine 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatoblastoma × codrituzumab × 1 year × Clear all
NCT04928677 2026-02-17

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
50 enrolled
Gastrointestinal

Simpson-Golabi-Behmel syndrome, Recurrence, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡